Metraipolis › archive › dc_616fbac2f71d

Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B — Europe PMC PMID:42405762

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42405762
DOI: 10.1128/spectrum.03424-25
License (as archived): solo-consultazione
Archived: 2026-10-15T17:56:41.159Z
SHA-256 of the archived text: 88df874e6249bdd437b665ae2b3b26b8feb5d28c51b3485c790a6c490cf3d7e1
Stable URL of this page: https://metraipolis.com/documento/dc_616fbac2f71d

How to cite

Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B — Europe PMC PMID:42405762 — Europe PMC (en), https://europepmc.org/article/MED/42405762 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_616fbac2f71d (Metraipolis archive dc_616fbac2f71d, sha256 88df874e6249bdd437b665ae2b3b26b8feb5d28c51b3485c790a6c490cf3d7e1)

BibTeX

@misc{dc616fbac2f71d,
  title = {Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B — Europe PMC PMID:42405762},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42405762},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_616fbac2f71d; sha256 88df874e6249bdd437b665ae2b3b26b8feb5d28c51b3485c790a6c490cf3d7e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42405762. Agents can read the archived copy with the MCP tool read_document.